Next-Generation Chimeric Antigen Receptor T-cells
The U.S. Food and Drug Administration (FDA) approved 6 CAR T cell (CAR-T) products, including tisagenlecleucel (tisa-cel), axicabtagene ciloleucel (axi-cel), brexucabtagene autoleucel (brexu-cel), lisocabtagene maraleucel (liso-cel), idecabtagene vicleucel (ide-cel), and ciltacabtagene autoleucel (c...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer Medknow Publications
2022-07-01
|
| Serie: | Hematology/Oncology and Stem Cell Therapy |
| Accesso online: | https://journals.lww.com/10.56875/2589-0646.1035 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|